Rigel Pharmaceuticals (RIGL) 3.56 $RIGL After Hours

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Rigel Pharmaceuticals (RIGL) 3.56 $RIGL

After Hours Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Mar 06, 4:42PM CST

VEEV: 24.63 (-0.10), NG: 3.26 (-0.19), CRIS: 3.04 (-0.29), EVTC: 21.77 (+0.27), GTN: 12.60 (+0.29), SM: 44.49 (-1.81), MNKD: 5.47 (-0.26), RIGL: 3.56 (+0.26), EXK: 1.96 (-0.09), WBAI: 14.50 (+0.70)

Rigel (RIGL) Down on Wider Q4 Loss, Revenues Increase Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 04, 8:10AM CST
Rigel Pharmaceuticals, Inc.'s (RIGL) fourth-quarter 2014 loss of 25 cents per share was in line with the Zacks Consensus Estimate.
AZN: 66.27 (-1.91), BMY: 65.12 (-0.93), THRX: 19.60 (-0.26), RIGL: 3.56 (+0.26)

Rigel Pharma ups revenues 48% in Q4
Seeking Alpha - at Seeking Alpha - Tue Mar 03, 8:14AM CST

RIGL: 3.56 (+0.26)

Rigel reports 4Q loss
Automated Insights - Tue Mar 03, 6:54AM CST
SOUTH SAN FRANCISCO, Calif. (AP) _ Rigel Pharmaceuticals Inc. (RIGL) on Tuesday reported a loss of $22.3 million in its fourth quarter.
RIGL: 3.56 (+0.26)

Rigel Pharmaceuticals beats by $0.01, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Mar 03, 6:32AM CST

RIGL: 3.56 (+0.26)

Rigel Announces Fourth Quarter and Year End 2014 Financial Results
PR Newswire - Tue Mar 03, 6:30AM CST
Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today reported financial results for the fourth quarter and year ended December 31, 2014. For the fourth quarter of 2014, Rigel reported a net loss of $22.3 million, or $0.25 per share, compared to a net loss of $16.9 million, or $0.19 per share, in the fourth quarter of 2013. Weighted average shares outstanding for the fourth quarters of 2014 and 2013 were 87.8 million and 87.4 million, respectively.
RIGL: 3.56 (+0.26)

Rigel Pharmaceuticals (RIGL) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 03, 6:18AM CST
Rigel Pharmaceuticals (RIGL) Shares March Higher, Can It Continue?
RIGL: 3.56 (+0.26)

Notable earnings before Tuesday’s open
Seeking Alpha - at Seeking Alpha - Mon Mar 02, 4:30PM CST

SSI: 20.94 (+0.19), PRIM: 17.23 (-0.29), ACW: 4.72 (-0.25), DKS: 56.44 (+0.14), TPH: 14.66 (-0.31), TEDU: 10.24 (+0.21), BBEP: 7.50 (-0.16), BBY: 39.71 (+0.08), BNS: 51.19 (-0.95), RIGL: 3.56 (+0.26), INSY: 57.69 (+0.08), AZO: 645.20 (-5.77), NAV: 29.86 (-0.44), JD: 28.62 (-0.38), KATE: 32.82 (-0.44)

Bristol-Myers to Buy Flexus, Team Up with Rigel - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 24, 5:54PM CST
Bristol-Myers (BMY) is strengthening its immuno-oncology pipeline through the acquisition of Flexus Biosciences and a collaboration with Rigel Pharmaceuticals.
AGN: 233.51 (-1.90), LLY: 68.41 (-2.18), BMY: 65.12 (-0.93), RIGL: 3.56 (+0.26)

Nasdaq stocks posting largest volume increases
AP - Tue Feb 24, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
LARK: 26.24 (+0.27), SLXP: 158.01 (+0.57), BIOC: 3.10 (-0.26), VASC: 28.66 (-0.69), AXPW: 0.18 (-0.01), FCCY: 11.69 (+0.31), RIGL: 3.56 (+0.26), REXI: 9.05 (-0.10), HLSS: 18.42 (-0.03)

Most active Nasdaq-traded stocks
AP - Tue Feb 24, 12:17PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:
MU: 28.50 (-0.78), FB: 80.00 (-1.21), DISCB: 33.59 (-1.31), SLXP: 158.01 (+0.57), DISCA: 33.08 (-0.48), BIOC: 3.10 (-0.26), CMCSK: 59.91 (+0.06), INTC: 33.19 (-0.54), RIGL: 3.56 (+0.26), FSLR: 60.61 (-1.05), DISCK: 31.77 (-0.38), CYTX: 1.11 (-0.05), MSFT: 42.36 (-0.75), AAPL: 126.60 (+0.19), CMCSA: 60.37 (+0.04), CSCO: 28.92 (-0.38), HLSS: 18.42 (-0.03)

Why Shares of Rigel Pharmaceuticals Inc. Exploded Today
Alex Planes, The Motley Fool - Motley Fool - Mon Feb 23, 12:33PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Rigel Pharmaceuticals are trading more...
BMY: 65.12 (-0.93), RIGL: 3.56 (+0.26)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Feb 23, 11:44AM CST

HNH: 43.18 (-1.34), MELA: 1.83 (+0.02), CYBR: 59.78 (-3.09), OTIV: 1.24 (-0.02), CERU: 8.12 (+0.14), CLDX: 29.39 (-0.39), BIOC: 3.10 (-0.26), AXN: 1.49 (+0.37), SPPI: 6.26 (+0.02), NSLP: 7.65 (-0.05), RIGL: 3.56 (+0.26), VRTB: 3.61 (+0.30), WBAI: 14.50 (+0.70), BLCM: 24.48 (+0.13), SFY: 3.12 (-0.12), TSEM: 17.50 (-0.31), PTCT: 71.13 (-1.59), HOTR: 2.04 (-0.03), PRTA: 26.12 (-0.46), DGLY: 12.81 (+0.43)

Bristol-Myers Commits Up to $1.25 Billion to Add Flexus Cancer Therapies
at The Street - Mon Feb 23, 10:14AM CST
The pharma giant is making an upfront payment of $800 million and committing to up to $450 million more in milestone payments.
BMY: 65.12 (-0.93), RIGL: 3.56 (+0.26), CELG: 118.03 (-2.68)

Bristol-Myers adds to cancer-treatment push with acquisition
AP - Mon Feb 23, 8:48AM CST
NEW YORK (AP) — Bristol-Myers Squibb is using an acquisition that could be worth more than $1 billion and a separate collaboration agreement to continue its push into developing cancer treatments that use a patient's immune system to attack the disease.
RIGL: 3.56 (+0.26)

Bristol-Myers and Rigal Pharma team up in cancer therapeutics
Seeking Alpha - at Seeking Alpha - Mon Feb 23, 8:21AM CST

BMY: 65.12 (-0.93), RIGL: 3.56 (+0.26)

Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Mon Feb 23, 8:14AM CST

VRX: 198.71 (-5.24), OIBR: 2.06 (-0.11), CLDX: 29.39 (-0.39), HSBC: 42.81 (-0.78), ASTI: 1.43 (-0.02), AXN: 1.49 (+0.37), SPPI: 6.26 (+0.02), BIOC: 3.10 (-0.26), NBG: 1.43 (-0.08), RIGL: 3.56 (+0.26), BLDP: 2.29 (-0.06), MHR: 2.52 (-0.13), CSC: 68.86 (-1.00), PPO: 59.23 (+0.10), GERN: 3.50 (-0.28), ACI: 1.10 (-0.02), TSEM: 17.50 (-0.31), HOTR: 2.04 (-0.03), DGLY: 12.81 (+0.43), HLSS: 18.42 (-0.03), XOMA: 3.57 (-0.08)

Lion Biotechnologies names Ryan Maynard as director and chair of Audit Committee
M2 - Wed Feb 18, 6:44AM CST
Biotechnology company Lion Biotechnologies (Other OTC:LBIO) said on Tuesday that its board of directors has elected Ryan Maynard as its director and chair of the audit committee with immediate effect.
LBIO: 9.00 (-0.56), RIGL: 3.56 (+0.26)

Lion Biotechnologies Appoints Ryan Maynard Director and Chair of Audit Committee
GlobeNewswire - Tue Feb 17, 7:01AM CST
Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TIL), today announced that its board of directors has appointed Ryan Maynard to serve as a director and chair of the audit committee. His appointment is effective immediately.
LBIO: 9.00 (-0.56), RIGL: 3.56 (+0.26)

CGEN, RIGL, SPRT, AMRN, STON, PFH Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Mon Feb 02, 4:02AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Compugen Ltd (NASDAQ:CGEN), Rigel Pharmaceuticals Inc (NASDAQ:RIGL), Support.com Inc (NASDAQ:SPRT), Amarin Corp PLC (NASDAQ:AMRN), Stonemor Partners L.P. (NASDAQ:STON), Corporate Asset Backed Corp (NYSE FH) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
STON: 28.24 (+0.09), AMRN: 1.78 (+0.11), SPRT: 1.74 (+0.03), CGEN: 8.13 (-0.14), PFH: 18.33 (-0.34), RIGL: 3.56 (+0.26)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nevada Expands Rural Youth Mental Health Access

Updated Category News Views 171

Nevada's Rural Mental Health Crisis When you're navigating the barren stretches of rural Nevada, the scenic views can be breathtaking. But for many families, finding basic services like mental health care is as challenging as striking water in the desert. Cartwheel Care has taken the bull by the horns with their latest initiative to bridge this glaring gap. Partnering...

Continue Reading
LongueVue Capital: Betting Big on Sports & Entertainment

Updated Category News Views 90

LongueVue Capital's Bold Move You don’t always hear about private equity firms diving head-first into the sports and entertainment sector, but LongueVue Capital (LVC) is doing just that. This New Orleans-based firm is shifting its gears and setting sights on founder-owned ventures crucial to these industries. They’re asking the key question: Why focus on just the...

Continue Reading
Teamsters Ratify Contract, Averting Waste Strike

Updated Category News Views 25

Big Win for Teamsters Local 350 You ever seen a strike averted by sheer willpower and unity? That’s what's happened here with the workers at South San Francisco Scavenger Company. These folks—drivers, mechanics, sorters, and utility workers—all banded together under the Teamsters Local 350 and showed management what's what by securing a contract they deserve. We're...

Continue Reading
AR Cards in Casino Gaming: A High-Stakes Revolution

Updated Category News Views 31

A New Breed of Casino Experience Walk into a casino today, and you might just enter a whole new reality. No, this isn’t a cheesy magician’s trick or a glitzy PR stunt—this is the real deal brought to you by augmented reality (AR) trading cards. Imagine the slots you love wrapped in a sci-fi movie where characters leap out, tap you on the shoulder, and call you by...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 95

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
FDA Changes Shake Up Medtech Inspections Landscape

Updated Category News Views 124

Inspecting the Changing FDA Landscape If you’ve been treating FDA inspections like a ride down memory lane, it's time for a wake-up call. What F. David Rothkopf plans to tell the medical device teams at the MEDevice Silicon Valley event is simple: the game has changed. The FDA’s Quality Management System Regulation (QMSR) that kicked in on February 2, 2026, isn’t...

Continue Reading
Sivers Semiconductors: Strategy Behind 2027 AGM Plans

Updated Category News Views 234

Setting the Stage for a Crucial Year Ah, the dance of corporate governance—an arena where maneuvering is an art. Sivers Semiconductors AB, a name that's becoming synonymous with innovation in the photonics and wireless solutions sector, is prepping for its 2027 Annual General Meeting. Ahead of this pivotal event, they're forming a Nomination Committee to shape future...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 39

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Paris Baguette Expands U.S. Presence with New Georgia Café

Updated Category News Views 148

Café Culture Meets Expansion Chase You ever sip a cup of coffee and hear the rustle of opportunity in the steam? That's what's brewing at Paris Baguette with their new opening in Peachtree Corners, Georgia. This isn't just another café setting up shop; it's part of a larger scheme—expanding their sweet slice of the global market pie. Paris Baguette's Georgia Gamble...

Continue Reading
Ranger and Smith Unveil Tea-Infused Chocolate Bar

Updated Category News Views 63

Fresh Collaborations in Portland's Culinary Scene Ah, the sweet crossover in Portland's food scene is once again in the spotlight with a new entry that's sure to titillate taste buds. Ranger Chocolate Co. and Steven Smith Teamaker are at it again, rolling out a delectable creation that merges the poetic elegance of tea with the indulgent richness of chocolate. Welcome,...

Continue Reading

Top 5 Most Recently Viewed Articles

Algeness® VL Filler Receives Marketing Approval in China

Updated Category News Views 273

Exciting Developments for Advanced Aesthetic Technologies Advanced Aesthetic Technologies, Inc. (AAT) recently celebrated a significant milestone with the approval of their Algeness® VL agarose facial injection filler for marketing in China. This landmark achievement opens up new avenues for AAT in expanding their product offerings in the Asian market and showcases their...

Continue Reading
Criminal Charges Anticipated in Trump Campaign Hacking Case

Updated Category News Views 154

Criminal Charges Expected in Trump Campaign Hacking Case U.S. authorities are preparing to file criminal charges regarding an incident in which the Trump campaign claimed its internal communications were hacked, allegedly by the Iranian government. This concerning situation has drawn the attention of both the public and officials, raising serious issues surrounding...

Continue Reading
Semler Scientific Faces Class Action Lawsuit: What Investors Need to Know

Updated Category News Views 187

Semler Scientific and the Class Action Lawsuit Overview In recent news, a class action lawsuit has taken center stage involving Semler Scientific, Inc. (SMLR). Investors who have experienced losses related to their investments in Semler are advised to take note of this development, which may directly impact their financial outcomes. Understanding the Lawsuit This class...

Continue Reading
FTC Solar Engages Investors at Key Industry Conferences

Updated Category News Views 159

FTC Solar Engages Investors at Key Industry Conferences FTC Solar, Inc. (Nasdaq: FTCI), an innovative leader in solar tracker systems and engineering services, is set to make significant strides in connecting with investors at three prominent conferences. These events provide a platform for the management team, including CEO Yann Brandt, to engage in discussions that...

Continue Reading
Anixa Biosciences Set to Share Innovations in Cancer Therapy

Updated Category News Views 88

Anixa Biosciences Set to Conduct a Notable Presentation Anixa Biosciences, Inc. (NASDAQ: ANIX), a leading biotechnology firm dedicated to the treatment and prevention of cancer, has taken a significant step forward by announcing its participation in a prestigious investment conference. This event, the H.C. Wainwright 27th Annual Global Investment Conference, promises to...

Continue Reading